Correlation Between Takeda Pharmaceutical and MERCK Kommanditgesells
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and MERCK Kommanditgesells at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and MERCK Kommanditgesells into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and MERCK Kommanditgesellschaft auf, you can compare the effects of market volatilities on Takeda Pharmaceutical and MERCK Kommanditgesells and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of MERCK Kommanditgesells. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and MERCK Kommanditgesells.
Diversification Opportunities for Takeda Pharmaceutical and MERCK Kommanditgesells
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Takeda and MERCK is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and MERCK Kommanditgesellschaft au in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MERCK Kommanditgesells and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with MERCK Kommanditgesells. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MERCK Kommanditgesells has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and MERCK Kommanditgesells go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and MERCK Kommanditgesells
Considering the 90-day investment horizon Takeda Pharmaceutical is expected to generate 1.25 times less return on investment than MERCK Kommanditgesells. But when comparing it to its historical volatility, Takeda Pharmaceutical Co is 2.2 times less risky than MERCK Kommanditgesells. It trades about 0.01 of its potential returns per unit of risk. MERCK Kommanditgesellschaft auf is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 17,229 in MERCK Kommanditgesellschaft auf on January 25, 2024 and sell it today you would lose (1,393) from holding MERCK Kommanditgesellschaft auf or give up 8.09% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 99.78% |
Values | Daily Returns |
Takeda Pharmaceutical Co vs. MERCK Kommanditgesellschaft au
Performance |
Timeline |
Takeda Pharmaceutical |
MERCK Kommanditgesells |
Takeda Pharmaceutical and MERCK Kommanditgesells Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Takeda Pharmaceutical and MERCK Kommanditgesells
The main advantage of trading using opposite Takeda Pharmaceutical and MERCK Kommanditgesells positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, MERCK Kommanditgesells can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MERCK Kommanditgesells will offset losses from the drop in MERCK Kommanditgesells' long position.Takeda Pharmaceutical vs. Viatris | Takeda Pharmaceutical vs. Elanco Animal Health | Takeda Pharmaceutical vs. Zoetis Inc | Takeda Pharmaceutical vs. Emergent Biosolutions |
MERCK Kommanditgesells vs. Greater Cannabis | MERCK Kommanditgesells vs. Merck KGaA ADR | MERCK Kommanditgesells vs. For The Earth | MERCK Kommanditgesells vs. Indo Global Exchange |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |